Skip to main content
. Author manuscript; available in PMC: 2019 Jul 26.
Published in final edited form as: Genes Immun. 2018 Sep 24;20(6):493–499. doi: 10.1038/s41435-018-0046-8

Table 4.

Effect of genotypes of FCGR3A gene on pulmonary function test in the CBD patients at time of initial CBD diagnosis (FEV1, FVC, TLC, DLCOU were adjusted for gender, race, age, and height).

FEV1 FEV1PP FVC FVCPP TLC TLCPP DLCOU DLCOUPP
FF 3.3 (1.6-5.9) 96 (47-123) 4.21 (2.37-7.23) 91 (68-121) 6.70 (4.63-9.38) 107.5 (77-137) 29.91 (15.37-51.41) 93 (44-140)
FV 3.1 (1.1-4.8) 89 (35-126) 4.13 (1.22-6.57) 85 (31-126) 6.67 (3.09-9.64) 104 (46-137) 31.64 (7.83-57.60) 89 (20-152)
VV 3.0 (2.0-4.5) 92 (50-123) 3.92 (2.60-6.08) 94 (62-122) 6.5 (3.99-10.65) 104 (73-154) 27.73 (15.53-40.15) 86 (43-122)
p value 0.19 0.415 0.09 0.249 0.55 0.136 0.09 0.207